Osborne Partners Capital Management, LLC Iridex Corp Transaction History

Osborne Partners Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	SELL	$1.62 - $2.91 $16,200 - $29,100	-10,000 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$1.78 - $2.51 $26,700 - $37,650	-15,000 Reduced 60.0%	10,000 $20,000
Q1 2020 Apr 29, 2020	SELL	$1.4 - $3.64 $1,400 - $3,640	-1,000 Reduced 3.85%	25,000 $40,000
Q3 2019 Oct 25, 2019	SELL	$1.57 - $4.43 $15,700 - $44,300	-10,000 Reduced 27.78%	26,000 $49,000
Q1 2019 Apr 24, 2019	SELL	$4.14 - $5.18 $24,839 - $31,080	-6,000 Reduced 14.29%	36,000 $164,000
Q4 2018 Jan 28, 2019	SELL	$3.85 - $6.3 $57,750 - $94,500	-15,000 Reduced 26.32%	42,000 $197,000
Q1 2018 Apr 19, 2018	SELL	$5.72 - $8.28 $66,151 - $95,758	-11,565 Reduced 16.87%	57,000 $326,000
Q4 2017 Jan 25, 2018	SELL	$7.62 - $9.94 $24,864 - $32,434	-3,263 Reduced 4.54%	68,565 $522,000
Q3 2017 Oct 19, 2017	BUY	$8.19 - $10.25 $588,271 - $736,237	71,828	71,828 $673,000

3.25M

500

61.3K

Ticker IRIX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 15,985,600
Market Cap $22.2M
Description
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...

Get notified when there are updates to the investment portfolio of Osborne Partners Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Osborne Partners Capital Management, LLC with notifications on news.